Labo’Life 2LC1 (30 Capsules)

(1 customer review)

CAD $179.00

THIS IS C1 NOT CL1

Out of stock

Product Code: LABOC1GB Category: Tags: , Brand:

Product Description

Please allow up to 3 weeks extra for delivery of this product.

The immune system is our organism´s best ally in the fight against pathogens. Micro-Immunotherapy, in turn, is an effective ally for the immune system.

Supports the immune system with oncological indications associated with solid tumors, as well as in the case of conventional oncological therapies.

Share your thoughts!

5 out of 5 stars

1 review

Let us know what you think...

0 reviews with a 1-star rating

There are no reviews with a 1-star rating yet

×

Login

Create Account

Continue as a Guest

Don't have an account? Sign Up

Per 10 capsules

Interleukin 1 (IL-1): 6-10 CH
Interleukin 2 (IL2): 3-10 CH
Interleukin 4 (IL4): 6-10 CH
Interleukin 6 (IL6): 6-10 CH
Interleukin 7 (IL7): 6 -10 CH
Interfer. Alpha (IFN-α): 3-10CH
Interfer. Gamma (IFN-γ): 6-10 CH-
dimethyl. Sulfoxid. (DMSO): 3-10 CH
Epiderm. Cresc. Fact (EGF): 10-15 CH
Transform. Cresc. Fact. Beta (TGF-β): 10-30CH
Molgramostim (GMCSF): 5-10 CH
Tum. NECR. Fact. Alpha (TNF-α): 5-10 CH
Acid. Desoxyribonucleic (DNA): 10-12-30-200K
Acid Ribonucleic. (RNA): 6-10-12-30-200K
Acid. Nucleic. Specif. SNA-HLA I: 10-16 ° C
Acid. Nucleic. Specif. SNA-HLA II: 10-16 CH
Acid. Nucleic. Specif. SNA-C1a:
10-16 CH Acid. Nucleic. Specif. SNA-C1b: 10-16CH
Excip. Lactos. Saccharos. Pro caps. gel. una.

Treatment: 1 capsule per day until stabilization of the biological markers.
Modification or relapse, or during heavy treatments: 1 to 3 capsules per day for 1 to 3 months, then 3 months 1 capsule per day.

Step 1: Take the blister out of the carton
Step 2: Take a capsule according to the number
Step 3: Open the capsule
Step 4: Take the contents of the capsule under the tongue

Warnings:

Consult a healthcare practitioner before use if you are pregnant or breastfeeding.

Always read and follow the label.

You may also like…

Pin It on Pinterest

Share This